These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17852000)

  • 21. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial.
    Sokal DC; Karim QA; Sibeko S; Yende-Zuma N; Mansoor LE; Baxter C; Grobler A; Frolich J; Kharsany AB; Miya N; Mlisana K; Maarshalk S; Karim SS
    Antivir Ther; 2013; 18(3):301-10. PubMed ID: 22914267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid-lowering effect of tenofovir in HIV-infected patients.
    Fabbiani M; Bracciale L; Doino M; Sidella L; Farina S; Di Cristo V; Cauda R; De Luca A; Di Giambenedetto S
    J Antimicrob Chemother; 2011 Mar; 66(3):682-3. PubMed ID: 21131692
    [No Abstract]   [Full Text] [Related]  

  • 23. Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.
    Giguere R; Carballo-Diéguez A; Ventuneac A; Mabragaña M; Dolezal C; Chen BA; Kahn JA; Zimet GD; McGowan I
    Cult Health Sex; 2012; 14(2):151-66. PubMed ID: 22084840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
    Hoel N; Shaikh S; Kagee A
    Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents.
    Joanis CL; Hart CW
    AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.
    Karim QA; Kharsany AB; Frohlich JA; Baxter C; Yende N; Mansoor LE; Mlisana KP; Maarschalk S; Arulappan N; Grobler A; Sibeko S; Omar Z; Gengiah TN; Mlotshwa M; Samsunder N; Karim SS
    Trials; 2011 Mar; 12():67. PubMed ID: 21385354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
    Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
    J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carraguard acceptability among men and women in a couples study in Thailand.
    Martin S; Blanchard K; Manopaiboon C; Chaikummao S; Schaffer K; Friedland B; Kilmarx PH
    J Womens Health (Larchmt); 2010 Aug; 19(8):1561-7. PubMed ID: 20575712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
    van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
    Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study.
    Joglekar NS; Joshi SN; Navlakha SN; Katti UR; Mehendale SM
    Indian J Med Res; 2006 Apr; 123(4):547-52. PubMed ID: 16783046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
    Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
    [No Abstract]   [Full Text] [Related]  

  • 32. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
    Olsen ML; Cwiak CA; Koudelka C; Jensen JT
    Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM
    Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi.
    Woodsong C; Alleman P
    AIDS Educ Prev; 2008 Apr; 20(2):171-87. PubMed ID: 18433322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific microbicides in the prevention of HIV infection.
    Kelly CG; Shattock RJ
    J Intern Med; 2011 Dec; 270(6):509-19. PubMed ID: 21917029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sexual partnership patterns as a behavioral risk factor for sexually transmitted diseases.
    Finer LB; Darroch JE; Singh S
    Fam Plann Perspect; 1999; 31(5):228-36. PubMed ID: 10723647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's attitudes to condoms and female-controlled means of protection against HIV and STDs in south-western Uganda.
    Hart GJ; Pool R; Green G; Harrison S; Nyanzi S; Whitworth JA
    AIDS Care; 1999 Dec; 11(6):687-98. PubMed ID: 10716009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
    BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectal microbicide acceptability: results of a volume escalation trial.
    Carballo-Diéguez A; Exner T; Dolezal C; Pickard R; Lin P; Mayer KH
    Sex Transm Dis; 2007 Apr; 34(4):224-9. PubMed ID: 16906126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.